Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.

Clinical trial NCT04552600 · COMPLETED

Trial details

NCT number: NCT04552600
Sponsor: Natureceuticals Sdn Bhd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2019-09-01
Primary completion: 2022-08-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.